IRIT ARBEL

Corporate Board Profile

Tech Score: 0/100

← Back to All Directors

BRAINSTORM CELL THERAPEUTICS INC.

Filing Date Source Excerpt
2005-03-01 "Irit Arbel 45 Director" and "Dr. Irit Arbel joined the Company in April 2004 as a director"
2006-08-22 Nominee for Class I Director: Irit Arbel 46 Director ... Dr. Irit Arbel joined the Company in May 2004 as a director and as our President. ... In the fiscal year ended March 31, 2006, we paid our directors the following compensation: (i) Dr. Irit Arbel received an aggregate of $10,000 and was issued an option to purchase 100,000 shares of our Common Stock
2006-11-20 "Irit Arbel" is listed in the beneficial ownership table under "Directors and Named Executive Officers."
2008-04-29 The Board of Directors has determined that each of Dr. Arbel, Dr. Javitt, Mr. Lion and Dr. Shorr, constituting all of the directors of the Company, satisfies the criteria for being an “independent director”... The Audit Committee currently consists of Mr. Lion (Chairman) and Drs. Arbel and Shorr... Dr. Irit Arbel (*) ... Total ... 127,750
2012-05-07 The Board of Directors has determined that each of Dr. Arbel... satisfies the criteria for being an “independent director”... The Audit Committee currently consists of Mr. Friedman (Chair), Dr. Arbel and Mr. Pinkas... The GNC Committee currently consists of Dr. Arbel (Chair), Dr. Shorr and Mr. Taub... Director Compensation Table for Fiscal 2011 ... Dr. Irit Arbel ... Total ($) 130,365

Source material: SEC submissions metadata and DEF 14A proxy filings from EDGAR. Last updated: 2026-05-06